LXRepair is a French high technology and innovative start-up that has built its foundation on over 25 years of experience in the science behind DNA repair mechanisms. As a proud contributor to the expansion of personalized cancer medicine, LXRepair offers a wide range of products and services in the field of oncology. Their innovative biomarkers provide a complete functional signature for DNA repair mechanisms, which is now utilized as part of powerful tools for personalized cancer treatment.

Some of the products offered by LXRepair include ExSy-SPOT, Glyco-SPOT, and NEXT-SPOT, which are used for DNA repair characterization. Additionally, LXRepair provides services such as clinical investigations and partnership opportunities. With a dedicated team of experts, including Founder and Chief Scientific Officer Sylvie Sauvaigo, CEO Stéphane Altaba, and Chief Financial Officer François-Xavier Desforges, LXRepair is at the forefront of advancements in DNA repair and oncology diagnostics